Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Charmacy Pharmaceutical Co., Ltd. has announced a board meeting scheduled for August 28, 2024, to discuss and approve the interim results for the first half of the year and to consider the declaration of an interim dividend. The meeting will also include public disclosure of the company’s financial performance. The notice, issued on August 16, 2024, includes a list of the company’s current executive and non-executive directors.
For further insights into HK:2289 stock, check out TipRanks’ Stock Analysis page.